Genestra Brands Maxum Multi Vite
Natural health product licensed in Canada
- Licence holder
- Seroyal International
- NPN or DIN-HM
- 80027402
- Status
- Active licence
- Licence date
- 22 September 2011
- Revision date
- 11 April 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Manganèse: up to 8 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Chrome: up to 80 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 80 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 34 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 34 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3-Pyridinecarboxamide Source : Niacinamide | 20 mg | Not calculated |
| Zinc Source : Oxyde de zinc | 5 mg | 10,000 µg |
| Manganèse Source : Sulfate de manganèse | 4 mg | 8,000 µg |
| Chrome Source : Chloride | 40 mcg | 80 µg |
| Chrome Source : Produit de chélation de chrome et de PVH | 40 mcg | 80 µg |
| L-glutathion Source : L-Glutathione | 2 mg | Not calculated |
| Acide d-pantothénique Source : D-pantothénate de calcium | 50 mg | Not calculated |
| Magnésium Source : Citrate de magnésium | 20 mg | 40,000 µg |
| Sélénium Source : Sélénométhionine | 40 mcg | 80 µg |
| Vitamine D Source : Cholécalciférol Potency : 15 UI | 0.38 mcg | 0.76 µg |
| Vitamine A Source : Palmitate de vitamine A Potency : 1,500 UI | 450 mcg EAR | Not calculated |
| Molybdène Source : Fumarate de molybdène | 10 mcg | 20 µg |
| Molybdène Source : Citrate de molybdène | 10 mcg | 20 µg |
| Molybdène Source : Malate de molybdène | 10 mcg | 20 µg |
| Molybdène Source : Succinate de molybdène | 10 mcg | 20 µg |
| Molybdène Source : Glutarate de molybdène | 10 mcg | 20 µg |
| Inositol Source : Inositol | 15 mg | Not calculated |
| Quercétine-3-ruténoside Source : Dimorphandra mollis seed pod | 2 mg | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 17 mg | 34,000 µg |
| Vitamine B6 Source : 5-phosphate de pyridoxal | 17 mg | 34,000 µg |
Non-medicinal ingredients
Stéarate de magnésium, Microcrystalline cellulose, Silice, Hypromellose, Silicate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
An antioxidant for the maintenance of good health. Helps in the development and maintenance of bones, cartilage, teeth, gums and night vision; provides support for healthy glucose metabolism; helps the body to metabolize carbohydrates, fats and proteins; helps in the function of the thyroid gland, in wound healing and normal growth and development; helps in tissue, connective tissue and red blood cell formation; helps to maintain eyesight, healthy skin, membranes, immune and proper muscle function; helps to prevent vitamins C, E, B6, B12, pantothenic acid, biotin, thiamine, riboflavin, manganese, chromium and selenium deficiencies. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Helps to maintain the body's ability to metabolize nutrients.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80027402
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging